Abstract

ABSTRACTMass immunisation is a central aspiration of global health programmes, such as in the 2000 Millennium Development Goals (MDG), as a means of addressing the glaring inequalities in life expectancy that separate the Global North and South. A recent initiative, the Human Papillomaviruses (HPV) vaccine, is being rolled out in so-called developing countries to prevent a number of sexually transmitted diseases, including one of the rarer forms of cervical cancer. Despite its apparent good intentions, resistance to the vaccine has occurred, in developed as well as in developing countries, not least because it constitutes a largely gendered form of medical intervention which is promoted according to Western concepts of risk, biomedical knowledge and normative understandings of female sexual behaviour. As a major component of the MDG health strategy aimed at developing countries, the HPV vaccine initiative carries implicit tendencies towards ‘medical colonialism’ underpinned as it is by hegemonic scientific masculinity, in which gendered forms of structural violence are legitimised through the discursive affiliations of progress and global health. This paper will examine the intersecting themes of political economy, gendered structural violence and hegemonic medical masculinity underpinning HPV immunisation programmes within the context of development. It interrogates how masculine scientific narratives of disease prevention, which legitimises the state-endorsed (and increasingly mandated) pharmaceuticalised protection of young women as objects of patriarchal care and control, have become the new missionary voices, saving bodies rather than souls.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call